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A Commentary on
Type I CRISPR-Cas targets endogenous genes and regulates virulence to evademammalian host
immunity
by Li, R., Fang, L., Tan, S., Yu, M., Li, X., He, S., et al. (2016). Cell Res. 26, 1273–1287.
doi: 10.1038/cr.2016.135
Type-I CRISPR-Cas systems are abundant antiviral defense systems of bacteria and archaea.
The hallmark sequences of these systems are short CRISPR RNAs (crRNAs) that contain spacer
sequences which guide an interference complex termed Cascade (CRISPR-associated complex
for antiviral defense) toward their viral DNA target (van der Oost et al., 2014). In the recent
years, several subtypes of this Type I CRISPR-Cas system have been studied in detail and all
interference complexes share a central crRNA whose spacer is protected by a multi-subunit
filament of Cas7 (Csy3) backbone proteins (Gleditzsch et al., 2016). The termini of the CRISPR
RNA are capped by Cas5 (Csy2) and Cas6 proteins and additional large and small subunits can
mediate interactions with the target DNA, i.e., the protospacer and the protospacer-adjacent motif
(PAM). The crRNA spacer is used to scan DNA for complementary bases and the large subunit
identifies PAM sequences to achieve self- versus non-self-discrimination and to avoid self-targeting.
Finally, Cascade complexes recruit a helicase/nuclease, termed Cas3, to degrade identified DNAs
(Hochstrasser et al., 2014).
In a recent study in Cell Research (Li et al., 2016), Li et al., highlight a surprising deviation from
these established concepts and show self-targeting of the lasR mRNA based on only nine nucleotide
complementarity between the CRISPR RNA and the target mRNA, as well as the presence of a
small “5′-GGN-3′” recognition motif. Earlier studies have indicated that Escherichia coli Type I-E
Cascade can bind ssRNA in vitro (Jore et al., 2011) and that Cas3 can degrade ssRNA (Beloglazova
et al., 2011). However, specific DNA targeting is considered to be essential for proper identification
of foreign DNA elements while maintaining genome integrity. The described RNA targeting relies
on a discriminationmechanism similar to the established DNA targeting pathway and suggests that
a 5′-GGN-3′ PAM-like sequence must exist to mark the mRNA-target. However, a conventional
PAM sequence in Type I-F Cascade prevents base pairing between the 8 nt 5′-repeat-tag of the
crRNA and the DNA target (Rollins et al., 2015), while the identified PAM-like sequence in the
lasR mRNA would prevent base pairing with the 3′-tag (Figure 1A). This implies that Cascade
would have evolved a specific RNA target discrimination mechanism. The 3′-tag of a crRNA is
bound by Cas6f in Type I-F systems. Thus, this protein would be in the vicinity of the PAM-like
sequence, while Cas proteins involved in conventional PAM recognition are located at the opposite
end of the Cascade complex (Figure 1A). Surprisingly, a very short 9 bp sequence downstream of
the PAM-like sequence was sufficient for in vitro RNA cleavage by recombinant Cascade. Here,
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FIGURE 1 | RNA targeting by Type I-F Cascade (A) Schematic representation of a Type I-F Cascade complex with bound DNA. The approximate location of the
PAM near the large subunit (LSU, Csy1) is indicated. The reported target mRNA would bind at the opposite end of Cascade (near Cas7.6 and Cas6f). (B) The number
of targets for each Pseudomonas aeruginosa strain UCBPP-PA14 spacer (5′-GGN-3′ followed by nine base-pair complementarity) in the genome (total targets) and
transcriptome (mRNA targets) is indicated.
all nucleotides of this region were important, even though every
6th nucleotide is splayed out in the Type I-E Cascade structure
at the Cas7 backbone filament junctions and was found not to be
involved in base pairing with the target (Wiedenheft et al., 2011).
Thus, both PAM-like sequence and mRNA target recognition
clearly deviate from themechanisms established for conventional
DNA recognition by Cascade.
The authors did not investigate the impact of this non-
stringent mRNA targeting mechanism on the global bacterial
RNA metabolism. Therefore, we screened all CRISPR spacers
of the two CRISPR systems of Pseudomonas aeruginosa strain
UCBPP-PA14 for possible crRNA-mRNA interactions. A 5′-
GGN-3′ sequence, followed by 12 or 9 bp complementarity,
were considered to be requirements for potential interactions.
In total, 11 genomic targets were obtained for 12 nt spacer
matches. Five of these hits are located on mRNAs, while only
one hit is located in a non-coding region. Next, we reduced the
number of required continuous base pairs to nine nucleotides
as suggested for the described Type I-F Cascade in vitro lasR
mRNA decay activity. With these parameters, the crRNAs would
potentially target 422 host genome regions, of which 31 (7.3%)
are located in intergenic regions and 391 (92.7%) are present in
coding regions (Figure 1B). The sense strand (i.e., the mRNA)
is targeted for 189 of the 391 genes (48.3%). In conclusion,
there does not appear to be a selection against mRNA targeting.
The existence of this large number of potential targets suggests
two possible scenarios. First, CRISPR-Cas systems could play a
major role in regulating the abundance of individual mRNAs
and shape bacterial transcriptomes. Alternatively, the observed
RNA targeting of the lasR mRNA might be an exceptional
occurrence and cells would need to have evolved protection
mechanisms against off-target mRNA degradation. A global
analysis of transcriptome changes upon CRISPR-Cas induction
and/or deletion would be necessary to be able to differentiate
between these possibilities.
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